Trials in San Diego, California
Here are the top 10 medical studies for breast cancer in San Diego, California
Popular Filters
Phase 3 Trials
Hormone Therapy
Giredestrant + Palbociclib vs Letrozole + Palbociclib for Breast Cancer
Recruiting1 awardPhase 3
Orange, California
This trial will compare two treatments for breast cancer: giredestrant with palbociclib, and letrozole with palbociclib. The trial will measure how well the treatments work and how safe they are.
Antibody-Drug Conjugate
T-DXd for HER2 Positive Breast Cancer
Recruiting2 awardsPhase 3
San Diego, California
This trial is testing a new cancer drug called Trastuzumab deruxtecan in patients with advanced HER2-positive breast cancer that has not responded to other treatments. The drug targets cancer cells with a specific marker and delivers a powerful drug to kill them. The study includes patients with and without brain metastasis to see how well the drug works and how safe it is. Trastuzumab deruxtecan is a new type of treatment that has shown impressive results in patients who have already received many other treatments.
Selective Estrogen Receptor Degrader (SERD)
AZD9833 + Palbociclib for Breast Cancer
Recruiting1 awardPhase 3
La Mesa, California
This trial is comparing two drug combinations to treat a specific type of advanced breast cancer. One combination includes a new drug called camizestrant, and the other includes anastrozole. Both combinations also use palbociclib. The goal is to see which combination works better at slowing down the cancer.
Trials With No Placebo
Small Molecule Kinase Inhibitor
Tucatinib + Trastuzumab for HER2-Positive Cancers
Recruiting1 awardPhase 2
La Jolla, California
This trial is for people with solid tumors that make too much HER2 or a different type of HER2. Participants will get tucatinib and trastuzumab. People with hormone-receptor positive breast cancer will also get fulvestrant. The trial will look at side effects.
Monoclonal Antibodies
Trastuzumab Deruxtecan + Anastrozole for Breast Cancer
Recruiting1 awardPhase 2
Los Alamitos, California
This trial is investigating whether trastuzumab deruxtecan, either alone or in combination with anastrozole, is effective in treating patients with HER2 low, hormone receptor positive breast cancer.
Monoclonal Antibodies
AZD8701 + Durvalumab for Solid Cancers
Recruiting1 awardPhase 1
La Jolla, California
This trial is testing a new drug, AZD8701, alone and with an existing drug, Durvalumab, in adults with advanced cancers. The goal is to see if these treatments can stop cancer growth or help the immune system fight the cancer. The study focuses on patients whose cancers are hard to treat or have responded to similar treatments before. Durvalumab is a drug that helps the immune system fight cancer and has been used with other treatments to help patients live longer.
Selective Estrogen Receptor Modulator (SERM)
Lasofoxifene + Abemaciclib for Breast Cancer
Recruiting1 awardPhase 2
Fountain Valley, California
This trial is testing a combination of drugs to treat ER+/HER2- breast cancer that has progressed despite hormonal treatment. Lasofoxifene and abemaciclib will be given to see if the combination is safe and well tolerated.
Monoclonal Antibodies
SGN-B6A for Cancer
Recruiting1 awardPhase 1
Los Alamitos, California
This trial is testing a new drug called sigvotatug vedotin alone and with other treatments to see if it is safe and effective for people with solid tumors. It will also check for any side effects. The study includes different parts to determine the best dose and to see how well the drug works alone and in combination with other treatments.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.